Translate to...

Immunotherapy biomarker discovery could benefit thousands with Type 1 diabetes

Immunotherapy biomarker discovery could benefit thousands with Type 1 diabetes

Scientists at UCL have discovered new biomarkers, which may identify those people with Type 1 diabetes who would benefit from the immunotherapy drug Abatacept, a finding which could eventually help thousands manage the disease more effectively.